Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOC2017217 eye drops in early to mid-stage age-related cataract
CTR20230060Phase 2Active
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZOC2017217 in senile cataract (ARC), sponsored by Zhongshan Ophthalmic Center. Started May 2023; status: active.
02
Drugs
ZOC2017217
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on CTR20230060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230060.